Throughout October, CURE highlighted research developments and evolving treatment strategies that continue to shape cancer ...

REDWOOD CITY, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (Nasdaq: CHRS), today reported financial results for the third quarter ended September 30, 2025 and provided an overview ...

Percutaneous cryoablation yields outcomes comparable to robotic surgery for renal cancer, at significantly lower cost, Danish ...

When the kidneys are damaged—after surgery, cardiac arrest, or as a side effect of certain medications—doctors often face one ...

The results of a late-stage drug trial released Thursday are raising hopes that type 1 diabetes patients with chronic kidney ...

A rapid multidisciplinary approach is needed to reduce serum free light chain levels and restore kidney function ...

Park says patient-specific factors that influence his treatment selection include the presence of liver disease, ...

Investigators analyzed exfoliated cells in urine test specimens to identify 50 candidate RNAs for prostate cancer detection.